Immunocore Holdings plc (IMCR)
NASDAQ·Healthcare·Biotechnology
$28.93
+1.08%
Mkt Cap $1.69B
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$47.25
Range $36.00 – $60.00
Implied Upside
+63.3%
Consensus $47.25 vs current $28.93
NASDAQ·Healthcare·Biotechnology
$28.93
+1.08%
Mkt Cap $1.69B
No recent rating data.
Price Target (14 analysts)
$47.25
Range $36.00 – $60.00
+63.3%
Consensus $47.25 vs current $28.93